Addiction
How Psilocybin Affects Depression, Anxiety, and Substance Use in Real-Life Settings
While clinical trials have shown promise in treating depression, anxiety, and substance use disorders, little is known about how psilocybin
While clinical trials have shown promise in treating depression, anxiety, and substance use disorders, little is known about how psilocybin
Psychedelics may act as catalysts for nervous system regulation and embodied memory processing, bringing suppressed trauma to the surface.
Recent research suggests that psilocybin shows promise in treating addiction. Studies have demonstrated its potential efficacy in treating tobacco and
In our recent large-scale study of psilocybin, 4.6% of users reported using psilocybin while on an antidepressant.
Results from our recent large-scale study with John Hopkins University found significantly decreased depression persisting for months following psilocybin ingestion.
Psilocybin has been used safely for patients with OCD and was associated with acute reductions in core OCD symptoms in
From our naturalistic psilocybin study, the average initial dose of dried psilocybin mushrooms was 3.1 grams.
Data from our psilocybin study found that participants primarily used psilocybin with the intention of self-exploration, mental health, and therapy.
Data from our psilocybin study found that participants primarily reported using psilocybin alone (>40%), with friends who were also using
Nausea is a common side effect of psilocybin ingestion. Mushrooms are largely made up of chitin, which can cause gastrointestinal
©2025 Unlimited Sciences. All rights reserved.
We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.